William Lynch

Will is a currently a student in Boston University’s Graduate Program for Neuroscience. He previously received a Bachelor of Arts from Oberlin College, majoring in Neuroscience and minoring in Chemistry. Post-graduation he worked with Dr. Michael Beckstead at the Oklahoma Medical Research Foundation, conducting research assessing neuropeptide modulation of drug addiction-associated phenotypes and progressive single cell morphological decline within a mouse model of Parkinson’s disease. Findings from the latter project were featured on the cover Movement Disorders December 2018 edition. While working with Dr. Bryant, Will hopes to continue research investigating how genetic factors influence addictive behaviors. He is specifically analyzing how the conditional knockdown of the gene Hnrnph1, which encodes the RNA-binding protein hnRNP H1, alters methamphetamine-induced dopamine release and subsequent behavioral phenotypes.